Surmount Laboratories Limited, a active public limited company, was established on 28 March 1996 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH1996PLC098511. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹4.72 Cr.
It upholds a compliant status. Employing 19 professional, Its leadership includes Dhirendra Maganlal Mehta (Director), Kavit Dhirendrakumar Mehta (Director), Minesh Dhirendra Mehta (Director). Past directors included Heena Mayank Patel, Dhirendra Maganlal Mehta, Kavit Dhirendrakumar Mehta. It holds ₹24.00 Cr open charges and ₹24.80 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No. 305, Building No. 3, Wing C-2, Skyline Wealthspace Premises Chsl, Premier Road, Millar Compound, Vidyavihar West,, Mumbai, Maharashtra, 400086.
U24230MH1996PLC098511
098511
28 March 1996
₹6.00 Cr
₹4.72 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Surmount Laboratories Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dhirendra Maganlal Mehta | Director | 27 Aug 2020 | Current |
| Kavit Dhirendrakumar Mehta | Director | 31 Aug 2022 | Current |
| Minesh Dhirendra Mehta | Director | 04 Dec 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 May 2013 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Director | 25 Jun 2013 | Past |
| Pramod Abcsdd | Director | 05 Apr 2013 | Past |
| Pramod Abcsdd | Director | 07 Oct 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Surmount Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹240,000,000.00
₹248,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Dec 2023 | Others | ₹5.00 M | Open |
| 04 Oct 2022 | Others | ₹6.00 Cr | Open |
| 19 Mar 2016 | Others | ₹17.50 Cr | Open |
| 15 Nov 2022 | Others | ₹15.00 Cr | Satisfied |
| 27 Jun 2013 | Punjab National Bank | ₹7.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Surmount Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Surmount Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Surmount Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 15 Nov 2022 via Charge ID 100660651 with Others was fully satisfied on 01 Mar 2025. was completed.
Progress on A charge with Others of Rs. 17.50 Cr registered on 19 Mar 2016 with Charge ID 100025483 was modified on 04 Oct 2024. was documented.
The activity Surmount Laboratories Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Surmount Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
A charge with Others amounted to Rs. 0.50 Cr with Charge ID 100840948 was registered on 15 Dec 2023. was recorded as a recent event.
A charge with Others of Rs. 15.00 Cr registered on 15 Nov 2022 with Charge ID 100660651 was modified on 15 Jul 2023. was recorded as a recent event.
The CIN of Surmount Laboratories Limited is U24230MH1996PLC098511.
Surmount Laboratories Limited is headquartered at Office No. 305, Building No. 3, Wing C-2, Skyline Wealthspace Premises Chsl, Premier Road, Millar Compound, Vidyavihar West,, Mumbai, Maharashtra, 400086.
Surmount Laboratories Limited was incorporated on 28 March 1996.
The current directors of Surmount Laboratories Limited are
The primary industry of Surmount Laboratories Limited is Manufacturing.
Surmount Laboratories Limited is unlisted.
The authorized capital of Surmount Laboratories Limited is ₹6.00 Cr, and the paid-up capital is ₹4.72 Cr.
The compliance status of Surmount Laboratories Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX